History
Times change. SyntroMed keeps evolving. Our mission remains the same: safeguarding people's health.
In 1936, founder Lin Chin-Chih, driven by a desire to help people through medicine, rode his bicycle from door to door, delivering packets of medicine. He was among the pioneers in introducing pharmaceutical technology from the United States to Taiwan, founding Pharmaceutical Factory and opening a new chapter in western medicine manufacturing. He often said, “Making medicine is a matter of ethics.” Every product had to be one that he and his family could trust before it reached the public.
SyntroMed has a long history of developing diverse products from natural ingredients—including the once widely recognized roundworm treatment "Haishan Tablets", the contraceptive "Zanting Tablets", and "THROUGH F.C. TABLETS "C.M."(SENNOSIDES)", a leading laxative under Taiwan's National Health Insurance system. These products reflect SyntroMed's longstanding expertise in developing medicines from naturally derived active ingredients to meet people's healthcare needs.
As SyntroMed approaches its centennial, SyntroMed is developing plant-derived anticancer drug candidates and has launched the "Healthcare Package", a comprehensive self-care solution spanning prevention, treatment, and wellness. The Group is also expanding internationally, with the goal of becoming a global pharmaceutical and healthcare brand that helps people better care for themselves and those around them.
SyntroMed has a long history of developing diverse products from natural ingredients—including the once widely recognized roundworm treatment "Haishan Tablets", the contraceptive "Zanting Tablets", and "THROUGH F.C. TABLETS "C.M."(SENNOSIDES)", a leading laxative under Taiwan's National Health Insurance system. These products reflect SyntroMed's longstanding expertise in developing medicines from naturally derived active ingredients to meet people's healthcare needs.
As SyntroMed approaches its centennial, SyntroMed is developing plant-derived anticancer drug candidates and has launched the "Healthcare Package", a comprehensive self-care solution spanning prevention, treatment, and wellness. The Group is also expanding internationally, with the goal of becoming a global pharmaceutical and healthcare brand that helps people better care for themselves and those around them.
2020s
2010s
2000s
1980s
1960s
1930s
2020s to Present
A Champion of Self-Care
Addressing Diverse User Needs, Supporting Every Step of the Healthcare Journey
With cutting-edge pharmaceutical technology, we have continued to develop safe, effective, and convenient self-medication products.
We are here to protect everyone's health and help people achieve a wonderful life.
With everyone's help, Chung Mei has been able to persevere and head towards the future.
We expect ourselves to fulfill our corporate responsibilities and to give back to our community by doing good for the public.
For nearly a century, Chung Mei Pharma Group has received multiple international honors such as the National Brand Yushan Award, Chinese Public Welfare Golden Award Symbol of National Quality Award, and also became an ambassador of the Charity Festival of Chinese.
Chung Mei Pharma Group upholds our five core values as we protect everyone's health.
Let us go forward, hand-in-hand, to create a beautiful life with health and happiness every day.
With cutting-edge pharmaceutical technology, we have continued to develop safe, effective, and convenient self-medication products.
We are here to protect everyone's health and help people achieve a wonderful life.
With everyone's help, Chung Mei has been able to persevere and head towards the future.
We expect ourselves to fulfill our corporate responsibilities and to give back to our community by doing good for the public.
For nearly a century, Chung Mei Pharma Group has received multiple international honors such as the National Brand Yushan Award, Chinese Public Welfare Golden Award Symbol of National Quality Award, and also became an ambassador of the Charity Festival of Chinese.
Chung Mei Pharma Group upholds our five core values as we protect everyone's health.
Let us go forward, hand-in-hand, to create a beautiful life with health and happiness every day.
/
2026
- Invited to be featured in PharmaBoardroom, an international pharmaceutical publication, in an interview titled “Driving Transformation Through Innovation: Leading SyntroMed into a New Century.”
- SyntroMed partnered with the Ministry of Health and Welfare and the Tzu Chi Foundation to launch the Health Equity Program. By combining corporate resources with Tzu Chi’s long-established community service network, the initiative enables more older adults and family caregivers to access accurate, practical health information in their daily lives.
- Mobilized community pharmacists across Taiwan to deliver 72 community lectures on health equity and donated 5,000 vitamin C products and health care packages, helping older adults strengthen medication safety and health-care awareness.
- Launched its 90th-anniversary brand transformation campaign, unveiling a new brand film and corporate identity, “SyntroMed.” The initiative signals the company’s evolution from a traditional pharmaceutical manufacturer into a platform-based enterprise integrating pharmaceuticals, health supplements, pharmacist channels, community philanthropy, and health services.
2025
- Featured in an interview with the Los Angeles Times, highlighting how the company builds innovation on its heritage and leads the pharmaceutical industry toward a new future.
- In response to the September flooding in Guangfu Township, Hualien, the Group immediately launched relief efforts and partnered with the Tzu Chi Foundation to prepare 1,430 “Health Care Kits.” Brand Director Lin Yi-lin also joined recovery work in the disaster area as a volunteer “shovel hero.”
- Continued its corporate partnership for the common good with Tzu Chi, donating 1,450 Health Care Kits to support humanitarian relief efforts in Taiwan and abroad.
- Once again received the 2025 Golden Award for Chinese Philanthropic Enterprises.
- Supported the cultural event “An Evening with Daishin Kashimoto, Concertmaster of the Berliner Philharmoniker, and Alessio Bax.”
2024
- SyntroMed signed a Corporate Partnership for the Common Good agreement with the Tzu Chi Foundation, joining forces to create shared value and advance ESG sustainability.
- Sponsored the arts and cultural event “NHK Symphony Orchestra: 2024 Taiwan Tour.”
- Organized a Charity Family Day attended by 100 employees and family members, featuring hands-on activities in assistive-device cleaning and disinfection and recyclable-waste sorting. In partnership with Tzu Chi, the event promoted sustainability and extended the cycle of care.
2023
- SyntroMed participated in a charity fair to raise funds for earthquake relief in Türkiye and Syria, with all proceeds donated to relief efforts.
2022
- SyntroMed was honored by the Ministry of Economic Affairs as an “Enterprise with More Than 50 Years of Operation.”
- Donated epidemic-prevention supplies to Hualien Tzu Chi Hospital in support of frontline healthcare workers.
2021
- In recognition of its longstanding commitment to social welfare, SyntroMed received both the “Chinese Public Welfare Ambassador Award” and the “Integrity Brand Golden Award” at the Chinese Public Welfare Festival.
- SyntroMed received the 2021 “Outstanding Director Award for Industrial and Mining Associations” and was honored at the 75th Industrial Festival Celebration.
- Supported the Zenan Homeless Social Welfare Foundation’s vaccination initiative for disadvantaged groups by donating medical supplies to help ease post-vaccination discomfort.
- Chairman Lin Ben-Yuan was named to Tatler Taiwan’s 2021 Asia’s Most Influential list.
- Launched the “Great Buddha’s 60th Anniversary” series of activities to promote Changhua’s distinctive tourism.
2020
- Received the prestigious National Brand Yushan Award in the Outstanding Enterprise category.
- Partnered with United Daily News for the second consecutive year to host health seminars providing comprehensive health information.
2010 to 2019
A Bridge Between Taiwan and the World
As health needs became increasingly diverse, we introduced a broader range of international pharmaceutical options.
/
2019
- New product launches: CANPASS Premium Protein Compound Nutritional Formula, CANPASS L-Glutamine, and CANPASS Natural Multivitamins.
- Established the “Cancer Knowledge” website to provide accurate information on nutritional support for cancer care.
- Co-hosted the “Cancer Knowledge 360°” seminar with United Daily News, sharing information on disease prevention, treatment, and everyday health management.
- Established a subsidiary in Singapore to expand the Group’s presence across ASEAN markets.
2018
- CM VITAMIN B2-B6 TABLETS、Pure algae oil capsule、CM Digest Health Tablet、Botanical Repair launched.
- Mr. Lin Ben-Yuan officially became the 3rd Chairman of SyntroMed
- Chairman Lin Ben-Yuan and Brand Director Lin Yi-lin traveled to Myanmar to support disaster relief efforts, distributing bean seeds to help local communities rebuild.
2017
- Chung Mei Biopharma Co., Ltd. officially began operation, and entered the research and development of botanical drugs, as well as cloud sales channels.
- Passed the GDP conformity assessment, meeting international standards and extending GMP’s rigorous quality principles to the storage and transportation of pharmaceuticals, ensuring product quality and packaging integrity throughout the process.
- CHUNG MEI I-Balance DHA PLUS received the Symbol of National Quality Award.
2016
- Expanded overseas sales, successfully entering Southeast Asian markets.
- Established Chung Mei Biopharma Co., Ltd. to develop plant-derived anticancer drug candidates.
- Collaborated with Professor Tsai Ying-Chieh on the development of Asia’s first probiotic product for depression support, PS128. Cheerful Capsules were launched.
- Participated in CPhI Shanghai, Vitafoods Asia in Hong Kong, Pharmedi in Viet Num.
- Zettoc Denture Adhesive was launched.
2015
- Established Chung Mei Tsang Chou Cultural & Educational Foundation.
- Participated in the Taiwan–Japan Industrial Collaboration Bridging Forum and signed a memorandum of understanding with Japan’s Bankyo Pharmaceutical Co., Ltd.
- Participated in the Taiwan-Japan Industry Collaboration Bridging Forum and signed an MOU with Bankyo Pharmaceutical Co., Ltd.
- Chairman Lin Ben-Yuan was elected Managing Supervisor of the Taiwan Pharmaceutical Manufacturer’s Association.
- Chairman Lin Ben-Yuan and Associate General Manager Lin Ming-Chuan appeared on the cover of Tatler Taiwan in a feature titled “Passing the Baton, Carrying the Legacy Forward,” highlighting Chung Mei’s spirit of corporate succession.
- Conducted GHP risk visitation with the Food and Safety Center of National Taiwan University.
- Received the “Business Entity with Excellent Performance Award” from the National Taxation Bureau.
2014
- Obtained PIC/S GMP certification, meeting the highest international standards for pharmaceutical manufacturing.
- Established Sendo Co., Ltd. to import and distribution of products in Japan.
- Launched Ko Hu Sin ANTI-COLD Capsules “C.M.”, the first cold medicine specially formulated for patients with hypertension in Taiwan.
- Launched the new health food brand “Love．Health Trend”.
- Collaborated with National Yang Ming University on a Probiotics Technology R&D Project, leading to the commercialization and launch of a new product.
- Collaborated with Hungkuang University on an Echinacea Technology R&D Project, leading to the launch of echinacea products.
- Participated in the Superior and Affordable Integration Demonstration Project organized by International Trade Administration, MOEA.
- Established a GMP/ ISO 22000 compliant food safety management system.
- Participated in the 2014 “Branding Taiwan Project” organized by the Industrial Development Administration Ministry of Economic Affairs.
- Introduced the Factory Management System -LEAN.
2013
- Launched the weight-management products “KOKO OIL Ocut Capsules” (non-prescription medicine) and “KOKOKG Combat Pack” (nutritional supplement).
- Established the Biotechnology Food Division to focus on the R&D and marketing of health foods.
- Established the LC New Business Division to expand partnerships with local regional pharmacy chains.
- Collaborated with National Yang-Ming University and Hungkuang University on research and development projects involving probiotic and echinacea technologies.
- Undertook a contract manufacturing for ointment products for Shyh Dar Pharmaceutical Industrial Co., Ltd.
- Participated in the Alliance Symposium on Strategies for Community Cancer Support Group.
- SHU TONG JIA Tablets “C.M.” received the Symbol of National Quality Award.
2012
- Former President Lin Tsang-Chou and Chairman Lin Ben-Yuan received the Symbol of National Quality Award from President Ma Ying-jeou
- Expanded into Macau market through a partnership with Medreich Kali Macau Limitada.
- PU-YUAN BIOTECH CO., LTD was renamed Sino Advance Biotech Co., Ltd.
- Chairman Lin Ben-Yuan was elected Chair of the 27th Pharmaceutical Business Development Committee of the Taiwan Pharmaceutical Manufacturer’s Association.
- Undertook an OEM contract for Yuluan Intense Solution “Daiyu” from Daiyu Pharmaceutical Co., Ltd.
- Launched ANTI-COLD COLD LIQUID（SUGAR FREE）, the first sugar-free anti-cold syrup.
2011
- Chairman Lin Tsang-Chou was named one of the “100 Outstanding Citizens of Changhua”.
- Established a representative office of Chung Mei Pharmaceutical Co., Ltd. in Beijing to expand its business in China.
- Participated in the China International Health Industry Expo and Beijing Food Expo.
2010
- TFDA certified the facility as compliant with cGMP standards for pharmaceutical and food manufacturing. Rhodiola rosea + Vitamin B Complex Capsules was launched as the company’s first food product.
- The Workforce Development Agency approved the company’s application for the Joint Program, which received a Bronze Award.
- Participated in the 1st China (Taizhou) International Medical Expo.
2000s
Partner in Everyday Care
Expanded our presence across pharmacies and retail chains, supporting people in Taiwan in their everyday self-care.
Chung Mei Pharma Group products have diverse distribution channels so customers can conveniently reach us whenever they need us the most.
Protecting the health of all family members with practical actions－Chung Mei Pharma Group has become the most rustworthy pharmaceutical brand in Taiwan's healthcare industry.
Chung Mei Pharma Group products have diverse distribution channels so customers can conveniently reach us whenever they need us the most.
Protecting the health of all family members with practical actions－Chung Mei Pharma Group has become the most rustworthy pharmaceutical brand in Taiwan's healthcare industry.
/
2009
- Donated NT$6 million worth of cash and medicines for epidemic prevention in flood-affected areas across central and southern Taiwan by Typhoon Morakot.
- Hosted the “Health Trend” Medication Campaignand the Community Pharmacy “Health Bus PaPaGO” Program nationwide.
- The Workforce Development Agency approved the company’s application for the Joint Program for the Elevation in Human Resources of Enterprises.
- Launched the “Health Trend” health foods series.
2008
- Established “Health Trend” as a pharmacy alliance brand.
2006
- Introduced the “OTC” brand mascot.
- Expanded into new distribution channels, including Watsons, COSMED, and advertisement distributors.
- Appointed as the exclusive distributor in Taiwan for Kobayashi Pharmaceutical’s denture cleanser.
- Established PU-YUAN BIOTECH CO., LTD.
2005
- Donated NT$6 million worth of medicines for epidemic prevention in flood-affected areas across central and southern Taiwan by Typhoon Morakot.
- Undertook an OEM contract for ANYFLUENZA TABLETS from San Hua Pharmaceutical Co., Ltd.
2004
- Passed cGMP Phase III Certification.
- Expanded OTC sales into Hong Kong, Shenzhen, and other cities in China through a partnership with Wah Tat Pharmaceutical Co. Ltd.
2003
- Passed cGMP Phase II Certification.
- Introduced German herbal teas to Taiwan.
- Undertook an ODM contract for SLEEPMAN TABLETS fromWHOLE WIN PHARMACEUTICAL CO., LTD.
- Undertook an ODM contract for Yuluan Solution “Daiyu” from Daiyu Pharmaceutical Co., Ltd.
2002
- Completed the Industrial Development Administration, Ministry of Economic Affairs’s “Health Food R&D Project—Acanthopanax,” confirming safety, quality, and immune-enhancing function.
- Received guidance for Point of Sale System from Administration of Commerce, MOEA
2001
- Passed cGMP Phase I Certification.
- Received guidance for Personal Digital Assistant from Administration of Commerce, MOEA
2000
- Lin Ben-Yuan was elected director of the Taiwan Pharmaceutical Manufacturer’s Association.
- Established an Overseas Business Division in Singapore to market and distribute beverages, health foods, and pharmaceutical products.
1980 to 1990s
Advancing Modern Pharmaceutical Manufacturing
Responding to the health challenges of urbanization through standardized, science-based production.
/
1999
- Participated in the Ministry of Economic Affairs’ R&D Assistance Program for Small and Medium-Sized Enterprises. The company’s in-house project, “Development of Sustained-Release Formulation Technology,” was approved for R&D support.
- Collaborated with the Pharmaceutical Industry Technology and Development Center on two projects: “Technical Evaluation and Development Support for Pellet Formulations” and “Formulation Design and Process Development for Long-Acting Multi-Symptom Cold Medicine Pellet Capsules.”
- Collaborated with the Development Center for Biotechnology on “Mass-Production Fermentation Technology for Lion’s Mane Mushroom Mycelium.” This marked Chung Mei Pharmaceutical’s formal entry into biotechnology and opened new directions for health food and pharmaceutical research and development.
- Partnered with Taiwan Kunyang Co., Ltd. and secured exclusive distribution rights in Taiwan for the patented “Ke-Wu-Tong Long-Acting Pain Relief Patch.”
- Partnered with the Tzu Chi Charity Foundation to support and sponsor the production of family medical and health kits for international disaster relief.
1998
- Collaborated with the Pharmaceutical Industry Technology and Development Center on two projects: a bioequivalence study of an Atenolol 100 mg/Chlorthalidone 25 mg combination tablet under the “Pharmaceutical Technology and Product Development” program, and a preliminary technology-licensing collaboration for the development of the Jin-Si-Gao Water-Based Medicated Patch.
1997
- Signed an agreement with Japan’s Lion Corporation and obtained exclusive distribution rights in Taiwan for SMILE A Eye Drops.
- Introduced female condoms from The Female Health Company (UK) Plc and obtained regional distribution rights.
1996
- Introduced an automated packaging machine for liquid formulations from Japan.
- Celebrated the company’s 60th anniversary in Macau.
- Established the Sea Lucky Logistics Center and commenced operations.
1995
- Introduced CENOVIS, Australia’s leading health supplement brand, to Taiwan with accessible pricing and open-shelf retail displays, ushering in a new era for the health supplement market.
1994
- Established the Chung Mei Health World Pharmacy Chain, helping affiliated traditional pharmacies transition to modern retail operations.
1988
- Completed construction of the new GMP manufacturing facility and commenced operations.
- Recognized by the competent industrial authority as a GMP-compliant pharmaceutical manufacturer.
1960s to 1970s
Partner in Public Health
Advancing public health and maternal and child healthcare while building a connected health network through member pharmacies.
/
1977
- Mr. Lin Ben-Yuan joined the management team as the company’s third-generation successor. During his tenure as General Manager, he introduced modern management systems, improved operational efficiency, and drove business growth.
1976
- Established Sea Lucky Enterprise Co., Ltd. to engage in the import and export of health supplements, Western medicines, medical devices, infant products, and related goods.
1972
- Exported Chung Mei products to Southeast Asia for the first time, marking the company’s expansion into international markets.
- Received regulatory approval to manufacture the traditional Chinese medicine product Tiao-Jing Zhong-Zi Pills.
1971
- Relocated to the current manufacturing site on Zhanglu Road in Dongfang Village, Changhua City, and commenced operations at the new facility.
- Established Mei Chou Drugs Co., Ltd., specializing in the distribution of imported pharmaceutical products.
1968
- Reorganized and expanded into Chung Mei Pharmaceutical Co., Ltd., with second-generation Chairman Lin Tsang-Chou assuming leadership of the company.
- President Lin Tsang-Chou and his wife attended the World Chinese Pharmaceutical Business Conference in Kuala Lumpur.
1967
- Chung Mei’s Cold Syrup was officially approved for sale.
1966
- Lin Tsang-Chou joined the management team as the company’s second-generation leader. He established a membership-based sales system, pioneered a distinctive distribution model within the pharmaceutical industry, and partnered with community pharmacies to safeguard public health.
- Hosted Chung Mei’s first homecoming banquet, inviting member-pharmacy owners and their families and laying the foundation for enduring relationships.
1930s to 1950s
Pharmacy on the Move
Bringing medicines directly to people during an era when healthcare resources were scarce.
/
1959
- Verified by Dr. Sun from the U.S. FDA as the very first Class A integrated pharmaceutical plant in central Taiwan.
1947
- Changed company name to “Chung Mei Pharmaceutical” and focused business on manufacturing western medicine.
1943
- Focused business on fighting malaria and was awarded for its success.
1936
- Mr. Lin Jin-Zhi founded “Chung Mi Drug Store,” selling over-the-counter medicine such as Tai-Chi Brand Ganji Tablets (roundworm medicine), Daluodi Solution (pesticide), and Guerming Eye Drops, which became popular all over Taiwan.
Award & Certificate